ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.78
0.00%
US Tech 100
19,821.60
-1.29%
S&P 500
5,842.63
1.12%
US Dollar vs CAD
1.43622
0.15%
Bitcoin
91,329.25
0.77%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Takeda Pharmaceutical Company Ltd (TAK) Share Price

Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical Company Ltd (TAK)

Taku Gold Corp
15.04
0.21
(1.42%)
Closed March 05 3:00PM
Delayed by 15 minutes
15.04
0.00
( 0.00% )
Pre Market: 5:25AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
15.04
Bid
-
Ask
-
Volume
4
0.00 Day's Range 0.00
12.575 52 Week Range 15.09
Market Cap
47.196B
Previous Close
15.04
Open
-
Last Trade
1
@
15.1
Last Trade Time
03:35:50
Financial Volume
-
VWAP
-
Average Volume (3m)
1,752,593
Shares Outstanding
3,138,026,928
Dividend Yield
4.11%
PE Ratio
1.07
Earnings Per Share (EPS)
45.91
Revenue
4.28T
Net Profit
144.07B

About Takeda Pharmaceutical Company Ltd

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geogr... Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
www.takeda.co.jp
Headquarters
Chuo, Tokyo, Jpn
Founded
1984
Takeda Pharmaceutical Company Ltd is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker TAK. The last closing price for Takeda Pharmaceutical was US$15.04. Over the last year, Takeda Pharmaceutical shares have traded in a share price range of US$ 12.575 to US$ 15.09.

Takeda Pharmaceutical currently has 3,138,026,928 shares outstanding. The market capitalization of Takeda Pharmaceutical is US$47.20 billion. Takeda Pharmaceutical has a price to earnings ratio (PE ratio) of 1.07.

Ask ADVFN Intelligence (AI)

TAK Latest News

More News

Form 13F-HR - Quarterly report filed by institutional managers, Holdings
Edgar (US Regulatory)
February 12 2025
TAK (1.42%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.775.3959355290814.2715.0914.27175491614.74400667DR
41.4310.506980161613.6115.0913.185155059414.05943311DR
121.4710.832719233613.5715.0912.86175259313.48562518DR
260.130.87189805499714.9115.0912.86171753313.80284986DR
520.432.9431895961714.6115.0912.575178897013.7450783DR
1560.21.3477088948814.8417.1512.28218225114.47239166DR
260-2.8-15.695067264617.842012.28216934115.29847236DR

TAK - Frequently Asked Questions (FAQ)

What is the current Takeda Pharmaceutical share price?
The current share price of Takeda Pharmaceutical is US$ 15.04
How many Takeda Pharmaceutical shares are in issue?
Takeda Pharmaceutical has 3,138,026,928 shares in issue
What is the market cap of Takeda Pharmaceutical?
The market capitalisation of Takeda Pharmaceutical is USD 47.2B
What is the 1 year trading range for Takeda Pharmaceutical share price?
Takeda Pharmaceutical has traded in the range of US$ 12.575 to US$ 15.09 during the past year
What is the PE ratio of Takeda Pharmaceutical?
The price to earnings ratio of Takeda Pharmaceutical is 1.07
What is the cash to sales ratio of Takeda Pharmaceutical?
The cash to sales ratio of Takeda Pharmaceutical is 0.04
What is the reporting currency for Takeda Pharmaceutical?
Takeda Pharmaceutical reports financial results in JPY
What is the latest annual turnover for Takeda Pharmaceutical?
The latest annual turnover of Takeda Pharmaceutical is JPY 4.28T
What is the latest annual profit for Takeda Pharmaceutical?
The latest annual profit of Takeda Pharmaceutical is JPY 144.07B
What is the registered address of Takeda Pharmaceutical?
The registered address for Takeda Pharmaceutical is 4-1-1 DOSHOMACHI, CHUO-KU, CHUO, TOKYO, 540-8645
What is the Takeda Pharmaceutical website address?
The website address for Takeda Pharmaceutical is www.takeda.co.jp
Which industry sector does Takeda Pharmaceutical operate in?
Takeda Pharmaceutical operates in the PHARMACEUTICAL DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SSTSystem1 Inc
US$ 0.7097
(51.03%)
29
NSANational Storage Affiliates Trust
US$ 50.99
(31.38%)
14
ZIPZipRecruiter Inc
US$ 7.09
(25.93%)
20
KUKEKuke Music Holding Limited
US$ 0.2588
(19.10%)
101
ACRACRES Commercial Realty Corporation
US$ 23.77
(18.02%)
2
CURBCurbline Properties Corp
US$ 16.12
(-33.39%)
45
LGF.BLions Gate Entertainment Corp
US$ 6.01
(-32.01%)
7
MEIMethode Electronics Inc
US$ 8.18
(-16.70%)
3.96k
RNGRRanger Energy Services Inc
US$ 13.11
(-14.76%)
6
LXULSB Industries Inc
US$ 5.91
(-14.22%)
7
BABAAlibaba Group Holding Limited
US$ 145.05
(2.85%)
749.77k
NIONIO Inc
US$ 4.38
(0.69%)
672.63k
BBAIBigBear ai Holdings Inc
US$ 4.62
(-3.75%)
298.49k
NUNu Holdings Ltd
US$ 10.57
(-2.76%)
235.16k
IONQIonQ Inc
US$ 22.24
(-1.72%)
184.07k

TAK Discussion

View Posts
Monksdream Monksdream 11 months ago
TAK over $10
👍️0
Boing x 2 Boing x 2 2 years ago
Just saying,

https://www.takeda.com/newsroom/newsreleases/2022/takedas-biologics-license-application-bla-for-dengue-vaccine-candidate-tak-003-granted-priority-review-by-us-food-and-drug-administration

4 months or less until an answer. Expedited review is six months or less now. It was accepted Nov 22nd.

Big if we get FDA apprvoval. ETF's in the know are sucking up shares.

Other approved drug has serious side effects vs. ours.

300M cases a year from mosquito bites.

Boing X 2
👍️0
Phosphene Phosphene 4 years ago
Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade

https://www.businesswire.com/news/home/20201208005955/en/Takeda%E2%80%99s-Pipeline-Has-Potential-to-Contribute-Significantly-to-Revenue-Growth-Over-Next-Decade
👍️0
Phosphene Phosphene 4 years ago
Japan's Takeda eyes new focus on vaccines after OTC asset sales - CEO

https://www.reuters.com/article/health-coronavirus-takeda-vaccines-idUSKBN27M0F7
👍️0
Phosphene Phosphene 4 years ago
MIT-Takeda program launches

Research projects will harness the power of artificial intelligence to positively impact human health.

https://news.mit.edu/2020/mit-takeda-program-launches-research-ai-and-human-health-0618
👍️0
rising rising 7 years ago
Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

ADR is 3:1 - NICE!
60 percent upside
Added 36.83 US stock
Added 29.38 US cash


Not a bad deal!
👍️0
rising rising 7 years ago
So how does the Shire shareholder make out on this deal?

Takeda shares tumbled as much as 9.3 percent in early trading in Tokyo on Wednesday. The Japanese company is offering the equivalent of 49 pounds ($68.55) per share, including 27.26 pounds in stock and 21.75 pounds in cash, Shire said in a statement. That’s a 60 percent premium to Shire’s closing share price on March 27, before Takeda disclosed it was interested in the US drug maker.

Where is the 60percent premium to Close of March 27 2018 at shire 128.87
👍️0
trendmkr trendmkr 9 years ago
Takeda article: enGene Shines with a Host of Big Name Collaborations

http://marketexclusive.com/engene-shines-with-a-host-of-big-name-collaborations/1281/
👍️0

Your Recent History

NYSE
TAK
Takeda Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads